Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System

Detalles Bibliográficos
Autores principales: Wang, Tiansheng, Lu, Wenchao, Tang, Huilin, Buse, John B., Stürmer, Til, Gower, Emily W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2019
Materias:
e-Letters: Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341287/
https://www.ncbi.nlm.nih.gov/pubmed/30530488
http://dx.doi.org/10.2337/dc18-1893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341287/
https://www.ncbi.nlm.nih.gov/pubmed/30530488
http://dx.doi.org/10.2337/dc18-1893

Ejemplares similares